NRX PHARMACEUTICALS INC - COM (NRXP)

CUSIP: 629444100

Q3 2023 13F Holders as of 30 Sep 2023

Share change
-6,179,453
Put/Call ratio
3.9%
SEC-reported price per share
$0.26
Indexed holders
33
Value change
-$2,984,364
Number of buys
11
Open additional details 1 more signal available
Number of sells
13

Security key

629444100

Report period

Q3 2023

Indexed institutions

33

Top holders

10

Ownership snapshot

Top reported holders of NRXP - NRX PHARMACEUTICALS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Daniel C. Javitt
Disclosed value leader
Daniel C. Javitt
Comparable rows
0/15
Latest evidence
30 Aug 2023
3/4/5 13F Highest disclosed value: $3,082,170 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Daniel C. Javitt has the largest disclosed position value at $3.08M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Daniel C. Javitt's linked filing trail.
Disclosed position value Top 5
Daniel C. Javitt $3.08M
BRAC Lending Group LLC $188.9K
Big Rock Partners Sponsor, LLC $166.1K
ARMISTICE CAPITAL, LLC $2.73M
VANGUARD GROUP INC $714.7K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Daniel C. Javitt
3/4/5
10%+ Owner
—
denominator unverified
$3,082,170
9,634,793 shares
— 29 Nov 2022
BRAC Lending Group LLC
3/4/5
10%+ Owner
—
denominator unverified
$188,880
590,435 shares
— 24 May 2021
Big Rock Partners Sponsor, LLC
3/4/5
10%+ Owner
—
mixed-class rows
$166,129
619,315 shares
mixed-class rows
— 24 May 2021
ARMISTICE CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$2,725,006
5,636,000 shares
— 30 Jun 2023
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$714,687
1,478,153 shares
— 30 Jun 2023
SABBY MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$338,320
699,731 shares
— 30 Jun 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
33
Shares
3,709,444
Indexed holders
33
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 indexed holders
32
Q3 2023 indexed holders
33
Indexed holder difference
1
Investor Q2 2023 Shares Q3 2023 Shares Share Diff Share Chg % Q2 2023 value Q3 2023 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .